Tag: NFL101
NFL BIOSCIENCES: PROMISING RESULTS OF THE PRECESTO CLINICAL STUDY REVEALING A LONG-LASTING EFFECT OF NFL-101 AND MODIFICATION OF THE COMMUNICATION STRATEGY OF THE RESULTS OF THE CESTO II STUDY – 09/25/2023 at 08:00
The PRECESTO clinical trial shows a clinically relevant reduction in smoking satisfaction in smokers not trying to quit with a more lasting effect than expected. The therapeutic potential of NFL-101…
NFL BIOSCIENCES: Agreement to grant its patent on NFL-101 in Europe and validation of the clinical development plan for NFL-101 by the EMA – 06/21/2023 at 18:15
NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of dependencies and addictions, announces that it has received approval from the…